Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
http://www.springerlink.com/index/pdf/10.1007/s13346-010-0003-1
Reference65 articles.
1. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681–13686
2. Betigeri S, Pakunlu RI, Wang Y, Khandare JJ, Minko T (2006) JNK1 as a molecular target to limit cellular mortality under hypoxia. Mol Pharm 3:424–430
3. Blokhina O, Fagerstedt KV (2010) Oxidative metabolism, ROS and NO under oxygen deprivation. Plant Physiol Biochem 48:359–373
4. Boning D, Rojas J, Serrato M, Reyes O, Coy L, Mora M (2008) Extracellular pH defense against lactic acid in untrained and trained altitude residents. Eur J Appl Physiol 103:127–137
5. Busl KM, Greer DM (2010) Hypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms. NeuroRehabilitation 26:5–13
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid-Drug Conjugates and Nanoparticles for the Cutaneous Delivery of Cannabidiol;International Journal of Molecular Sciences;2022-05-31
2. Nanoparticles in Chronic Respiratory Diseases;Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases;2022
3. Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus;Advanced Therapeutics;2020-10-13
4. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery;Expert Opinion on Drug Delivery;2020-10-08
5. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy;Theranostics;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3